-transparent.png){kind=logo}
The combination of cisplatin, vinblastine, and bleomycin (PVB) was used to treat a 25-year-old man for disseminated testicular germ cell cancer, leading to a complete remission. Acute nonlymphocytic leukemia (ANLL), resistant to chemotherapy, developed 5 years later. The secondary nature of this ANLL was corroborated by the detection of nonrandom chromosomal aberrations in bone marrow cells of chromosomes, 7, 5, and 3. This is one of the first reports of possible leukemogenic activity of PVB treatment when applied without additional irradiation or alkylating agents.
Related Publications
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
May 1988,
European heart journal,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
June 1986,
Cancer,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
April 1986,
Cancer treatment reports,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
October 1984,
Cancer,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
January 1993,
International urology and nephrology,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
October 1992,
Danish medical bulletin,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
February 1990,
BMJ (Clinical research ed.),
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
January 1990,
Neoplasma,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
September 1977,
Annals of internal medicine,
G W van Imhoff, and
D T Sleijfer, and
M H Breuning, and
G J Anders, and
N H Mulder, and
M R Halie
January 1984,
Progress in clinical and biological research,
